{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ceftriaxone+treatment&page=3", "query": { "intervention": "Ceftriaxone treatment", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 49, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ceftriaxone+treatment&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Ceftriaxone+treatment&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-02T09:20:44.964Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04869579", "title": "Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Selenium (as Selenious Acid)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "CHRISTUS Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2021-08-15", "completion_date": "2021-12-15", "has_results": false, "last_update_posted_date": "2021-08-03", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 1, "location_summary": "Longview, Texas", "locations": [ { "city": "Longview", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04869579" }, { "nct_id": "NCT00358202", "title": "Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pneumonia" ], "interventions": [ { "name": "cefepime", "type": "DRUG" }, { "name": "ceftriaxone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CPL Associates", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 69, "start_date": "2002-03", "completion_date": "2006-04", "has_results": false, "last_update_posted_date": "2007-10-31", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00358202" }, { "nct_id": "NCT01756924", "title": "Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prosthetic Joint Infections of Hip", "Prosthetic Joint Infections of Knee", "Infected Spacers" ], "interventions": [ { "name": "CEM-102", "type": "DRUG" }, { "name": "IV or Oral standard of care antibiotics", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arrevus Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2012-12", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2019-04-19", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 13, "location_summary": "Sarasota, Florida • Tamarac, Florida • Savannah, Georgia + 8 more", "locations": [ { "city": "Sarasota", "state": "Florida" }, { "city": "Tamarac", "state": "Florida" }, { "city": "Savannah", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01756924" }, { "nct_id": "NCT06080698", "title": "Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gram-negative Bacteremia" ], "interventions": [ { "name": "Intravenous Antibiotics", "type": "DRUG" }, { "name": "Oral Antibiotics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1030, "start_date": "2024-02-22", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 11, "location_summary": "San Francisco, California • Denver, Colorado • Baltimore, Maryland + 7 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06080698" }, { "nct_id": "NCT04870138", "title": "Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gonococcal Infection" ], "interventions": [ { "name": "Azithromycin", "type": "DRUG" }, { "name": "Ceftriaxone", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Neisseria gonorrhoeae strain FA1090 A26", "type": "BIOLOGICAL" }, { "name": "Neisseria gonorrhoeae strain FA7527", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "MALE", "summary": "18 Years to 35 Years · Male only" }, "enrollment_count": 16, "start_date": "2013-03-10", "completion_date": "2015-04-28", "has_results": true, "last_update_posted_date": "2021-12-02", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04870138" }, { "nct_id": "NCT05294588", "title": "Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gonorrhea Male" ], "interventions": [ { "name": "Cefixime", "type": "DRUG" }, { "name": "Ceftriaxone", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Neisseria gonorrhoeae strain FA1090", "type": "BIOLOGICAL" }, { "name": "Meningococcal Group B Vaccine", "type": "BIOLOGICAL" }, { "name": "Influenza Vaccine", "type": "BIOLOGICAL" }, { "name": "Tetanus-diptheria Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "MALE", "summary": "18 Years to 35 Years · Male only" }, "enrollment_count": 65, "start_date": "2022-04-18", "completion_date": "2026-02-05", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05294588" }, { "nct_id": "NCT03840811", "title": "Experimental Human Infection With Neisseria Gonorrhoeae", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gonococcal Infection" ], "interventions": [ { "name": "Cefixime", "type": "DRUG" }, { "name": "Ceftriaxone", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Neisseria gonorrhoeae strain FA1090 A26", "type": "BIOLOGICAL" }, { "name": "Neisseria gonorrhoeae strain FA7537", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "36 Years", "sex": "MALE", "summary": "18 Years to 36 Years · Male only" }, "enrollment_count": 27, "start_date": "2017-04-23", "completion_date": "2019-11-25", "has_results": true, "last_update_posted_date": "2021-03-23", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03840811" }, { "nct_id": "NCT01530763", "title": "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Infections", "Community Acquired Pneumonia" ], "interventions": [ { "name": "Ceftaroline fosamil", "type": "DRUG" }, { "name": "Ceftriaxone", "type": "DRUG" }, { "name": "amoxicillin clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Months to 18 Years" }, "enrollment_count": 161, "start_date": "2012-09", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2015-01-13", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 13, "location_summary": "Long Beach, California • Oakland, California • Orange, California + 10 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01530763" }, { "nct_id": "NCT00035347", "title": "Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Community-Acquired Pneumonia (CAP)" ], "interventions": [ { "name": "IV azithromycin", "type": "DRUG" }, { "name": "ceftriaxone", "type": "DRUG" }, { "name": "oral azithromycin", "type": "DRUG" }, { "name": "IV levofloxacin", "type": "DRUG" }, { "name": "oral levofloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 219, "start_date": "2001-01", "completion_date": "2002-06", "has_results": false, "last_update_posted_date": "2017-03-10", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Long Beach, California • Sylmar, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Sylmar", "state": "California" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Columbus", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00035347" }, { "nct_id": "NCT06611111", "title": "Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Post-Treatment Lyme Disease" ], "interventions": [ { "name": "Ceftriaxone (Rocephin®)", "type": "DRUG" }, { "name": "Dextrose 5% (D5W)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "State University of New York - Upstate Medical University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 44, "start_date": "2025-02-03", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-10-02T09:20:44.964Z", "location_count": 1, "location_summary": "East Syracuse, New York", "locations": [ { "city": "East Syracuse", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06611111" } ] }